zavegepant oral (BHV-3500 oral) / Pfizer 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zavegepant oral (BHV-3500 oral) / Pfizer
NCT04804033: A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Terminated
2/3
538
US
BHV-3500 (zavegepant), Placebo
Pfizer
Migraine
03/24
03/24
NCT06137703: A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers

Completed
1
52
US
Zavegepant 100mg non-enteric coated soft gel capsule, Treatment A, Zavegepant 100mg immediate release tablet, Treatment B, Zavegepant 2 x 100mg immediate release tablets, Treatment C, Zavegepant 4 x 25mg enteric coated soft gel capsule, Treatment D
Pfizer
Biological Availability
12/22
12/22
NCT04987944: Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

Terminated
1
45
Canada
Zavegepant, BHV3500, Placebo
Pfizer
Asthma
03/23
04/23

Download Options